|1.||Fivash, Mathew J: 1 article (11/2011)|
|2.||Diwan, Bhalchandra A: 1 article (11/2011)|
|3.||Kaczmarek, Monika Z: 1 article (11/2011)|
|4.||Salnikow, Konstantin: 1 article (11/2011)|
|5.||Kasprzak, Kazimierz S: 1 article (11/2011)|
|6.||Logsdon, Daniel L: 1 article (11/2011)|
|7.||Andrew, Angeline S: 1 article (07/2002)|
|8.||O'Hara, Kimberley A: 1 article (07/2002)|
|9.||Barchowsky, Aaron: 1 article (07/2002)|
|10.||Noreault, Trisha L: 1 article (07/2002)|
09/01/1988 - "Experiments were performed to study the earliest changes and their sequence in the development of malignant tumors following implantation of 10 mg of nickel subsulfide (Ni3S2) into the right quadriceps muscle of seven male Fischer rats. "
08/01/1986 - "A nickel subsulfide (Ni3S2) lung tumor model for the study of metal carcinogenesis was evaluated using intratracheally dosed B6C3F1 mice. "
01/01/1990 - "For nickel subsulfide treated animals, there was no evidence of a dose-related increase in pulmonary tumor response in any i.p. "
09/01/1988 - "The mechanism of malignant tumor induction by nickel subsulfide."
10/01/1987 - "Induction of ocular tumor by nickel subsulfide in the Japanese common newt, Cynops pyrrhogaster."
|2.||Sarcoma (Soft Tissue Sarcoma)
09/01/1979 - "Induction of sarcomas in nude mice by implantation of Syrian hamster fetal cells exposed in vitro to nickel subsulfide."
02/01/1978 - "Induction of testicular sarcomas in Fischer rats by intratesticular injection of nickel subsulfide."
02/01/1995 - "No local tumors developed at the injection site in the negative control rats or in rats that received the CoCrMo or TiAlV powders; poorly differentiated or pleomorphic sarcomas developed at the injection site in 10 of the 12 positive control rats that were treated with nickel subsulfide. "
09/01/1992 - "In this study, we examined nickel subsulfide (Ni3S2)- or Ni3S2/iron-induced renal sarcomas in F344 rats for the presence of transforming mutations in the K-ras oncogene. "
01/01/1979 - "Serum ceruloplasmin concentrations in rats with primary and transplanted sarcomas induced by nickel subsulfide."
03/25/1991 - "This study was designed to determine the effect of local inflammation on nickel subsulfide (Ni3S2) carcinogenesis. "
07/05/2002 - "Inhalation of particulate nickel subsulfide (Ni3S2) causes chronic active inflammation and fibrosis of the lungs. "
11/20/1995 - "Repeated inhalation of nickel subsulfide (Ni3S2) by F344/N rats for 3 months results in chronic active inflammation in the lung and atrophy of the olfactory epithelium. "
03/01/2002 - "Nickel oxide, cobalt sulfate, indium phosphide, talc, and nickel subsulfide studies showed chemical-related incidences of adrenal pheochromocytoma and significant (p < 0.01) associations with inflammation and fibrosis. "
01/01/1977 - "Dose-response and time-response study of erythrocytosis in rats after intrarenal injection of nickel subsulfide."
03/01/1982 - "Rats and guinea pigs developed pronounced erythrocytosis at one to four months after unilateral intrarenal (ir) injection of nickel subsulfide (Ni3S2). "
01/01/1977 - "Erythrocytosis was induced in Fischer rats by intrarenal (ir) injection of nickel subsulfide (Ni3S2) in dosages ranging from 0.6 to 10 mg per rat. "
07/01/1976 - "In rats, an intrarenal injection of nickel subsulfide (Ni3S2) regularly caused, within 2 months, an erythrocytosis and eventually a renal carcinoma in 40 per cent of the animals. "
07/01/1976 - "Renal carcinomas and erythrocytosis in rats following intrarenal injection of nickel subsulfide."
09/01/1984 - "Studies of the pathogenesis of arteriosclerosis induced in rats by intrarenal injection of a carcinogen, nickel subsulfide."
01/01/1982 - "Effects of unilateral nephrectomy on erythrocytosis and arteriosclerosis induced in rats by intrarenal injection of nickel subsulfide."
01/01/1982 - "Erythrocytosis, glomerulomegaly, mesangial hyperplasia, sialyl hyperplasia, and arteriosclerosis induced in rats by nickel subsulfide."
|2.||Ditiocarb (Sodium Diethyldithiocarbamate)
|3.||nickel monoxide (nickel oxide)